Cargando…
Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
OBJECTIVES: To find pharmacological options in post-COVID 19 Sildenafil therapy failure in men with before-COVID 19 onset and treated ED, starting from the fact that published studies proves COVID 19 as a risk factor for ED, as well as for Sildenafil loss efficacy in before COVID 19 started ED treat...
Autor principal: | Coca, Dr. Vasile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679762/ http://dx.doi.org/10.1016/j.jsxm.2022.10.123 |
Ejemplares similares
-
Covid 19 induced sildenafil lack efficacy is optimally improved by intra-urethral alprostadil
por: Coca, Vasile
Publicado: (2022) -
Plainte cognitive post-COVID-19 : profil et déterminants
por: Andriuta, Daniela, et al.
Publicado: (2022) -
A new part of life covid: female sexual dysfunction
por: Yazici, Serenay
Publicado: (2022) -
Dépistage des thromboses veineuses profondes par écho Doppler portatif chez les patients hospitalisés pour une infection au COVID-19 (COVID-TVP)
por: Fares, Yara, et al.
Publicado: (2022) -
Humoral response to 2-dose BNT162b2 mRNA vaccine for Covid-19 in liver transplant recipients
por: Guarino, M., et al.
Publicado: (2022)